Just topped up.What do people think will be the companies strategy for the share buy back of up to 13million shares or 10% of LRF.Last chance to top up before tommorrow
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%